Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143604 |
| CAS No | NA |
| Mol.F. | C17H17D3N2O2 |
| Mol.Wt. | 287.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143605 |
| CAS No | NA |
| Mol.F. | C55H83N21O22S2 |
| Mol.Wt. | 1454.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143606 |
| CAS No | NA |
| Mol.F. | C55H83N18O22S3 |
| Mol.Wt. | 1444.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143607 |
| CAS No | NA |
| Mol.F. | C14H15N3O2 |
| Mol.Wt. | 257.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143608 |
| CAS No | NA |
| Mol.F. | C35H43N9O4 |
| Mol.Wt. | 653.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143609 |
| CAS No | NA |
| Mol.F. | C10H20N4O |
| Mol.Wt. | 212.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143610 |
| CAS No | NA |
| Mol.F. | C13H14D4N2O4 |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143611 |
| CAS No | NA |
| Mol.F. | C13H13D5N2O4 |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143612 |
| CAS No | NA |
| Mol.F. | C13H9D9N2O4 |
| Mol.Wt. | 275.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143613 |
| CAS No | NA |
| Mol.F. | C53H51Cl2N9O18 |
| Mol.Wt. | 1172.9g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143614 |
| CAS No | NA |
| Mol.F. | C59H61Cl2N9O23 |
| Mol.Wt. | 1335.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143615 |
| CAS No | NA |
| Mol.F. | C18H27N3O5 |
| Mol.Wt. | 365.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143616 |
| CAS No | NA |
| Mol.F. | C5H7N3O |
| Mol.Wt. | 125.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143617 |
| CAS No | NA |
| Mol.F. | C17H25N3O5 |
| Mol.Wt. | 351.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143618 |
| CAS No | NA |
| Mol.F. | C17H22D2N4O3 |
| Mol.Wt. | 334.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143619 |
| CAS No | NA |
| Mol.F. | C17H21D3N4O3 |
| Mol.Wt. | 335.4 g/mole |
| INV STATUS | In Stock |